Inhaled mannitol as a test for bronchial hyper-responsiveness

References

• Woolcock AJ. Asthma. Murray JF, Nadel J (Eds). Saunders, PA, USA (1994).
   Google Scholar
• Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy59, 469–478 (2004).
   PubMed Web of Science ®Google Scholar
• Woolcock AJ, Peat J. Epidemiology of asthma in Australia. Official J. Aust. Chinese Med. Assoc.1(1), 5–7 (1995).
   Google Scholar
• British Guideline on the Management of Asthma. Thorax63(Suppl. 4), 1–121 (2008).
   PubMed Web of Science ®Google Scholar
• Sont JK, Han J, van Krieken JM et al. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax51, 496–502 (1996).
   PubMed Web of Science ®Google Scholar
• Brannan JD, Koskela H, Anderson SD, Chew N. Responsiveness to mannitol in asthmatic subjects with exercise- and hyperventilation-induced asthma. Am. J. Respir. Crit. Care Med.158(4), 1120–1126 (1998).
   PubMed Web of Science ®Google Scholar
• Munoz PA, Gomez FP, Manrique HA et al. Pulmonary gas exchange response to exercise- and mannitol- induced bronchoconstriction in mild asthma. J. Appl. Physiol.105(5), 1477–1485 (2008).
   PubMed Web of Science ®Google Scholar
• Holzer K, Anderson SD, Chan H-K, Douglass J. Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes. Am. J. Respir. Crit. Care Med.167(4), 534–547 (2003).
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma and management and prevention. In: NHLBI/WHO Workshop Report. National Institutes of Health, NIH, Lung and Blood Institute (Ed.). Medical Communication Resources, Inc., MD, USA, 16–19 (2007).
   Google Scholar
• Clearie KL, Fardon TC, Williamson PA et al. Supervised step-down in a community setting does not increase airways inflammation in mild to moderate asthmatics. Am. J. Resp. Crit. Care Med.179, A2798 (2009).
   Google Scholar
• Schoeffel RE, Anderson SD, Altounyan RE. Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline. BMJ283, 1285–1287 (1981).
   PubMed Web of Science ®Google Scholar
• Anderson SD. Is there a unifying hypothesis for exercise-induced asthma? J. Allergy Clin. Immunol.73, 660–665 (1984).
   PubMed Web of Science ®Google Scholar
• Findlay SR, Dvorak AM, Kagey-Sobotka A, Lichtenstein LM. Hyperosmolar triggering of histamine release from human basophils. J. Clin. Invest.67, 1604–1613 (1981).
   PubMed Web of Science ®Google Scholar
• Eggleston PA, Kagey-Sobotka A, Schleimer RP, Lichtenstein LM. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. Am. Rev. Respir. Dis.130, 86–91 (1984).
   PubMed Web of Science ®Google Scholar
• Anderson SD, Schoeffel RE, Finney M. Evaluation of ultrasonically nebulised solutions as a provocation in patients with asthma. Thorax38, 284–291 (1983).
   PubMed Web of Science ®Google Scholar
• Smith CM, Anderson SD. Inhalation provocation tests using non-isotonic aerosols. J. Allergy Clin. Immunol.84, 781–790 (1989).
   PubMed Web of Science ®Google Scholar
• Anderson SD, Smith CM, Rodwell LT et al. The use of non-isotonic aerosols for evaluating bronchial hyperresponsiveness. In: Provocation Challenge Procedures. Spector S (Ed.). Marcel Dekker, NY, USA, 249–278 (1995).
   Google Scholar
• de Meer G, Marks GB, de Jongste JC, Brunekreef B. Airway responsiveness to hypertonic saline: dose-response slope or PD15? Eur. Respir. J.25(1), 153–158 (2005).
   PubMed Web of Science ®Google Scholar
• de Meer G, Postma DS, Janssen NA, de Jongste JC, Brunekreef B. Bronchial hyper-reponsiveness to hypertonic saline and blood eosinophilic markers in 8–13 year old school children. Clin. Exp. Allergy34(8), 1226–1231 (2004).
   PubMed Web of Science ®Google Scholar
• Riedler J, Gamper A, Eder W, Oberfeld G. Prevalence of bronchial hyperresponsiveness to 4.5% saline and its relation to asthma and allergy symptoms in Austrian children. Eur. Respir. J.11, 355–360 (1998).
   PubMed Web of Science ®Google Scholar
• Riedler J, Reade T, Dalton M, Holst DI, Robertson CF. Hypertonic saline challenge in an epidemiological survey of asthma in children. Am. J. Respir. Crit. Care Med.150, 1632–1639 (1994).
   PubMed Web of Science ®Google Scholar
• Rabone S, Phoon WO, Anderson SD et al. Hypertonic saline challenge in an adult epidemiological field survey. Occup. Med.46, 177–185 (1996).
   Google Scholar
• Anderson SD, Spring J, Moore B et al. The effect of inhaling a dry powder of sodium chloride on the airways of asthmatic subjects. Eur. Respir. J.10, 2465–2473 (1997).
   PubMed Web of Science ®Google Scholar
• Anderson SD, Brannan J, Spring J et al. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am. J. Respir. Crit. Care Med.156, 758–765 (1997).
   PubMed Web of Science ®Google Scholar
• Parfitt K. Martindale: The Complete Drug Reference. Pharmaceutical Press, London, UK (1999).
   Google Scholar
• Brannan JD, Anderson SD, Freed R et al. Nedocromil sodium inhibits responsiveness to inhaled mannitol in asthmatic subjects. Am. J. Respir. Crit. Care Med.161, 2096–2099 (2000).
   PubMed Web of Science ®Google Scholar
• Brannan JD, Anderson SD, Gomes K et al. Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol. Am. J. Respir. Crit. Care Med.163, 1420–1425 (2001).
   PubMed Web of Science ®Google Scholar
• Brannan JD, Koskela H, Anderson SD, Chan H-K. Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects. Respirology7(1), 37–44 (2002).
   PubMed Web of Science ®Google Scholar
• Koskela H, Hyvärinen L, Brannan JD, Chan H-K, Anderson SD. Sensitivity and validity of three bronchial provocation tests to demonstrate the effect of inhaled corticosteroids in asthma. Chest124(4), 1341–1349 (2003).
   PubMed Web of Science ®Google Scholar
• Leuppi JD, Salome CM, Jenkins CR et al. Predictive markers of asthma exacerbations during stepwise dose-reduction of inhaled corticosteroids. Am. J. Respir. Crit. Care Med.163, 406–412 (2001).
   PubMed Web of Science ®Google Scholar
• Brannan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M. Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur. Respir. J.22(3), 491–496 (2003).
   PubMed Web of Science ®Google Scholar
• Gulliksson M, Palmberg L, Nilsson G, Ahlstedt S, Kumlin M. Release of prostaglandin D2 and leukotriene C in response to hyperosmolar stimulation of mast cells. Allergy61(12), 1473–1479 (2006).
   PubMed Web of Science ®Google Scholar
• Brannan JD, Gulliksson M, Anderson SD et al. Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing. Eur. Respir. J.27, 944–950 (2006).
   PubMed Web of Science ®Google Scholar
• Porsbjerg C, Brannan JD, Anderson SD, Backer V. Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients. Clin. Exp. Allergy38(1), 43–50 (2008).
   PubMed Web of Science ®Google Scholar
• Tomioka M, Ida S, Shindoh Y, Ishihara T, Takishima T. Mast cells in bronchoalveolar lumen of patients with bronchial asthma. Am. Rev. Respir. Dis.129, 1000–1005 (1984).
   PubMed Web of Science ®Google Scholar
• Brightling CE, Bradding P, Symon FA et al. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med.346(22), 1699–1705 (2002).
   PubMed Web of Science ®Google Scholar
• Carroll NG, Mutavdzic S, James AL. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur. Respir. J.19(5), 879–885 (2002).
   PubMed Web of Science ®Google Scholar
• Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J. Allergy Clin. Immunol.117(6), 1277–1284 (2006).
   PubMed Web of Science ®Google Scholar
• The MIMS Annual 1999. Caswell A (Ed.). MediMedia Australia Pty Ltd., Sydney, Australia, 2–92 (1999).
   Google Scholar
• Australian Approved Product Information for Aridol™ (mannitol powder for inhalation), Therapeutic Goods Administration approved version. March (2006).
   Google Scholar
• Daviskas E, Anderson SD, Brannan JD et al. Inhalation of dry powder mannitol increases mucociliary clearance. Eur. Respir. J.10, 2449–2454 (1997).
   PubMed Web of Science ®Google Scholar
• Daviskas E, Anderson SD, Eberl S, Chan H-K, Young IH. The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis. Chest119(2), 414–421 (2001).
   PubMed Web of Science ®Google Scholar
• Robinson M, Daviskas E, Eberl S et al. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study. Eur. Respir. J.14(3), 678–685 (1999).
   PubMed Web of Science ®Google Scholar
• Subbarao P, Brannan JD, Ho B et al. Inhaled mannitol identifies methacholine-responsive children with active asthma. Pediatr. Pulmonol.29, 291–298 (2000).
   PubMed Web of Science ®Google Scholar
• Brannan JD, Anderson SD, Perry CP et al. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a Phase 3 comparison study with hypertonic (4.5%) saline. Respir. Res.6, 144 (2005).
   PubMed Web of Science ®Google Scholar
• Currie GP, Haggart K, Brannan JD et al. Relationship between airway hyperresponsiveness to mannitol and adenosine monophosphate. Allergy58, 762–766 (2003).
   PubMed Web of Science ®Google Scholar
• Koskela H, Hyvärinen L, Brannan JD, Chan H-K, Anderson SD. Responsiveness to three bronchial provocation tests in patients with asthma. Chest124(6), 2171–2177 (2003).
   PubMed Web of Science ®Google Scholar
• Kersten ET, Driessen JM, van der Berg JD, Thio BJ. Mannitol and exercise challenge tests in asthmatic children. Pediatr. Pulmonol.44, 655–661 (2009).
   PubMed Web of Science ®Google Scholar
• The National Asthma Council. Asthma Management Handbook. National Asthma Council Australia Ltd., South Melbourne, Australia (2002).
   Google Scholar
• Godfrey S, Springer C, Bar-Yishay E, Avital A. Cut-off points defining normal and asthmatic bronchial reactivity to exercise and inhalation challenges in children and young adults. Eur. Respir. J.14(3), 659–668 (1999).
   PubMed Web of Science ®Google Scholar
• Avital A, Godfrey S, Springer C. Exercise, methacholine, and adenosine 5’-monophosphate challenges in children with asthma: relation to severity of disease. Pediatr. Pulmonol.30(3), 207–214 (2000).
   PubMed Web of Science ®Google Scholar
• Anderson SD, Brannan JD. Methods for ‘indirect’ challenge tests including exercise, eucapnic voluntary hyperpnea and hypertonic aerosols. Clin. Rev. Allergy Immunol.24, 63–90 (2003).
   Web of Science ®Google Scholar
• Expert Panel Report. Update on Selected Topics 2002: National Asthma Education and Prevention Program. National Institutes of Health, National Heart, Lung and Blood Institute. NIH publication no. 02-5074 (2003).
   Google Scholar
• Anderson SD, Charlton B, Weiler JM et al. Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma. Respir. Res.10, 4 (2009).
   PubMed Web of Science ®Google Scholar
• Spector S, Anderson SD, Charlton B, Weiler JM, Nichols S. Mannitol inhalation challenge: will it replace methacholine or histamine? Proc. Am. Thorac. Soc.6, 331 (2009).
   Google Scholar
• Crapo RO, Casaburi R, Coates AL et al. Guidelines for methacholine and exercise challenge testing – 1999. Am. J. Respir. Crit. Care Med.161, 309–329 (2000).
   PubMed Web of Science ®Google Scholar
• Koskela HO, Hyvärinen L, Brannan JD, Chan HK, Anderson SD. Coughing during mannitol challenge is associated with asthma. Chest125(6), 1985–1992 (2004).
   PubMed Web of Science ®Google Scholar
• Leuppi JD, Tandjung R, Anderson SD et al. Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept. Pulm. Pharmacol. Ther.18, 83–88 (2005).
   PubMed Web of Science ®Google Scholar
• de Nijs S, Fens N, Lutter R et al. Airway hyperresponsiveness to mannitol is associated with markers of airway inflammation in patients with COPD. Am. J. Respir. Crit. Care Med.179, A4328 (2009).
   Google Scholar
• Cockcroft DW, Davis BE. Diagnositic and therapeutic value of airway challenges in asthma. Curr. Allergy Asthma Rep.9, 247–253 (2009).
   PubMed Web of Science ®Google Scholar
• Pedersen L, Winther S, Backer V, Anderson SD, Larsen KR. Airway responses to eucapnic hyperpnea, exercise and methacholine in elite swimmers. Med. Sci. Sports Exerc.40(9), 1567–1572 (2008).
   PubMed Web of Science ®Google Scholar
• Holzer K, Anderson SD, Douglass J. Exercise in elite summer athletes: challenges for diagnosis. J. Allergy Clin. Immunol.110(3), 374–380 (2002).
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Murdock KY, Berscheid BA, Gore BP. Sensitivity and specificity of histamine PC20 determination in a random selection of young college students. J. Allergy Clin. Immunol.89, 23–30 (1992).
   PubMed Web of Science ®Google Scholar
• Liem JJ, Kozyrskyj AL, Cockroft DW, Becker AB. Diagnosing asthma in children: what is the role for methacholine bronchoprovocation testing? Pediatr. Pulmonol.43(5), 481–489 (2008).
   PubMed Web of Science ®Google Scholar